Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-020698
Filing Date
2022-07-29
Accepted
2022-07-29 16:01:31
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 2479156
2 ex31-3.htm EX-31.3 5620
3 ex31-4.htm EX-31.4 5457
4 ex32-1.htm EX-32.1 6263
5 ex32-2.htm EX-32.2 6527
  Complete submission text file 0001493152-22-020698.txt   6736253

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20211231.xsd EX-101.SCH 41122
7 XBRL CALCULATION FILE ogen-20211231_cal.xml EX-101.CAL 59486
8 XBRL DEFINITION FILE ogen-20211231_def.xml EX-101.DEF 159706
9 XBRL LABEL FILE ogen-20211231_lab.xml EX-101.LAB 347452
10 XBRL PRESENTATION FILE ogen-20211231_pre.xml EX-101.PRE 280196
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 623613
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32188 | Film No.: 221120710
SIC: 2834 Pharmaceutical Preparations